Showing results (411-420 of 528) with videos related to
Sort By:
Pageof 53
European Journal of Cancer (Oxford, England : 1990)|July 2, 2025
Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009-2023)Giovanni Maria Iannantuono, Charalampos S Floudas, Marco Filetti, et al.Cancer Biomarkers : Section a of Disease Markers|December 24, 2016
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutesAnna Caliò, Emilio Bria, Sara Pilotto, et al.Pharmacogenomics|August 7, 2008
The serine protease HtrA1 is a novel prognostic factor for human mesotheliomaAlfonso Baldi, Marcella Mottolese, Bruno Vincenzi, et al.Frontiers in Oncology|September 12, 2025
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumabSerena Eccher, Marco Sposito, Ilaria Trestini, et al.British Journal of Cancer|November 18, 2015
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancerFotios Loupakis, Roberto Moretto, Giuseppe Aprile, et al.Plos One|December 14, 2012
True 3q chromosomal amplification in squamous cell lung carcinoma by FISH and aCGH molecular analysis: impact on targeted drugsMatteo Brunelli, Emilio Bria, Alessia Nottegar, et al.Scientific Reports|July 4, 2020
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastasesMichele Basso, Salvatore Corallo, Maria Alessandra Calegari, et al.Breast (Edinburgh, Scotland)|March 17, 2024
Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patientsFederica Miglietta, Letizia Pontolillo, Carmine De Angelis, et al.Cancer Genetics|February 19, 2017
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitorsMatteo Brunelli, Albino Eccher, Luca Cima, et al.Journal of Cancer Research and Clinical Oncology|July 30, 2013
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinomaEleonora Brunello, Giuseppe Bogina, Emilio Bria, et al.Pageof 53